Oxiten

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxiten

Oxiten is a synthetic, long-acting medication classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Its sole active component, Tenoxicam, works to relieve symptoms like inflammation, pain, and fever by targeting the body's chemical response pathways, thereby providing comprehensive symptomatic relief.

Property Description
Active Ingredient Tenoxicam
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Subgroup Oxicam derivative (Thiazine derivative)
Common Forms Tablets, Lyophilized powder for injection, Suppositories, Topical gel
Origin Synthetic compound

What Type of Medicine is Oxiten (Tenoxicam)?

Oxiten is a single-component prescription medicine based on the International Nonproprietary Name (INN) Tenoxicam. It is formally categorized as an NSAID, belonging to the Oxicam group of enolic acid derivatives. A distinguishing feature of Tenoxicam, shared with related Oxicams, is its exceptionally long elimination half-life, which enables a once-daily regimen for patient convenience. This characteristic is clinically recognized for supporting sustained therapeutic coverage throughout the day and night. The drug's structure also contributes to a favorable profile within its class.

Composition and Available Forms of Oxiten

The medicine contains Tenoxicam (molecular formula C13H11N3O4S) as the active pharmacological agent. Oxiten is manufactured in several dosage forms to suit different routes of administration, including tablets for oral intake, lyophilized powder for injection for systemic use, suppositories for rectal use, and a topical gel for local application. Following systemic administration, Tenoxicam is notable for its high plasma protein binding, ensuring the drug is effectively retained to provide its sustained action throughout the system. This formulation diversity allows the active substance to be delivered efficiently, whether for general systemic effect or concentrated local action.

What is the General Therapeutic Purpose of Oxiten?

The general purpose of Oxiten is to provide integrated symptomatic control over the body's response to irritation and injury. The drug has an established triple action, as it is inherently anti-inflammatory (reducing swelling), analgesic (relieving pain), and antipyretic (lowering fever). This combined therapeutic action helps mitigate general discomfort and swelling, serving as a comprehensive agent for improving the patient's symptomatic state.

What side effects are possible with Oxiten?

Oxiten: Possible Side Effects and Safety Information

Official regulatory documents emphasize that the use of Oxiten carries several serious and life-threatening risks. These risks primarily relate to its effects on the central nervous system (CNS), including the potential for addiction, abuse, and misuse, which can lead to overdose and death.

Serious and Clinically Significant Adverse Reactions

The most significant safety concern is serious, life-threatening, or fatal respiratory depression, which can occur at any time during treatment, particularly upon initiation or following a dose increase. This risk is amplified when Oxiten is used concomitantly with benzodiazepines or other CNS depressants (including alcohol), potentially resulting in profound sedation and coma. Accidental ingestion, especially by a child, can result in a fatal overdose. Additional serious risks include severe hypotension (low blood pressure), adrenal insufficiency, increased intracranial pressure, and the potential for Neonatal Opioid Withdrawal Syndrome (NOWS) if used for a prolonged period during pregnancy.

Common Adverse Reactions

The most commonly reported adverse reactions observed in clinical trials (incidence greater than 5%) primarily involve the gastrointestinal and nervous systems. These reactions include constipation, nausea, somnolence (drowsiness), dizziness, vomiting, pruritus (itching), headache, dry mouth, asthenia (weakness), and sweating.

Safety Limitations

The established safety profile requires that patients be regularly assessed for behaviors related to addiction, abuse, and misuse. Due to the high risk of severe adverse effects, special caution and close monitoring are required for patients who are elderly, debilitated, or have underlying conditions such as chronic pulmonary disease. Abrupt discontinuation in a physically dependent patient can result in serious withdrawal symptoms.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The official regulatory documents define the potential overdose profile of Oxiten (Tenoxicam) by describing a spectrum of clinical manifestations and mandating specific emergency actions. Overdose presentations are often asymptomatic or may involve minor, self-limiting gastrointestinal symptoms such as nausea, vomiting, or epigastric discomfort.

Feature Documented Regulatory Statement
Severe Outcomes More severe consequences, which require urgent attention, include systemic effects like acute renal failure, convulsions, metabolic acidosis, or coma. Gastrointestinal complications such as bleeding or ulceration are also documented severe risks.
Immediate Action In the event of a suspected overdose, immediate medical advice must be sought, and the regional poison control centre should be contacted.

Regulatory Summary of Overdose Management

The official documentation clarifies that no specific antidote is known or available for acute NSAID toxicity. Management is therefore defined as supportive and symptomatic therapy to address any clinical manifestations as they arise, such as maintaining vital signs and monitoring for systemic damage. Although severity can vary significantly, immediate medical evaluation is strictly required if systemic or CNS symptoms manifest. Furthermore, regulatory notes indicate that elderly patients are recognized to be at greater risk for serious gastrointestinal complications during NSAID use, a risk factor relevant to severe overdose outcomes.

Therapeutic Uses of Oxiten

What Oxiten Treats: Main Uses and Benefits

Oxiten is relevant in contexts marked by increased discomfort or tension, and is commonly used across therapeutic domains where additional symptomatic support is needed. This medication is considered relevant for easing symptoms associated with inflammatory conditions, joint discomfort, and musculoskeletal disorders. As a part of this medication class, Oxiten is applied in clinical settings that involve acute or unstable symptom patterns.

The medication is applied in addressing symptom clusters that may become intense or disruptive, such as persistent swelling, joint stiffness, and localized pain. It is often used during phases when symptoms become more noticeable and create noticeable functional strain.

“This treatment provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.”

It supports general well-being during symptomatic phases and assists with maintaining functional stability.

Quick Fact: Symptomatic Relief for Physical Burden Oxiten is commonly used to help manage the physical strain of persistent inflammation and stiffness, which may be part of symptomatic management to support general well-being.

Regulatory References

  1. NIH StatPearls Antidepressants Overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Oxiten?

Oxiten (Tenoxicam) eligibility is strictly defined by regulatory authorities and is primarily intended for adults (18 years and older) who do not have documented health contraindications. Eligibility rules fall into three main categories: absolute prohibition, restricted use, and age limitations.

Absolute Contraindications

The medicine must not be used by patients who have:

  • An active or history of recurrent peptic ulceration or gastrointestinal hemorrhage.
  • Severe heart failure or severe renal or hepatic failure.
  • A known hypersensitivity to Oxiten, aspirin, or any other Nonsteroidal Anti-Inflammatory Drug (NSAID).
  • Third trimester pregnancy or are in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Restricted and Age-Based Use

Use is not recommended in children and adolescents as safety and efficacy are officially not established. Use during lactation is also not recommended. Women in the first or second trimester of pregnancy should only use the drug if clearly necessary.

Geriatric patients and individuals with mild-to-moderate organ impairment (renal or hepatic) or a history of uncontrolled hypertension require special caution and conditional use with careful monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies several categories of substances that interact with Oxiten, primarily affecting its concentration (pharmacokinetics) or combining effects on the central nervous system (pharmacodynamics).

Contraindicated and High-Risk Combinations

The label specifies that Oxiten is contraindicated for co-administration with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of discontinuing MAOI treatment. Use with alcohol is strongly restricted due to a documented risk of severe, additive depressant effects.

Interaction Type Interacting Substances (Examples)
Pharmacokinetic (Exposure) Strong CYP3A4 inhibitors (e.g., ketoconazole) and inducers (e.g., rifampin).
Pharmacodynamic (Additive Effects) Other CNS depressants (e.g., benzodiazepines, sedatives), serotonergic drugs.

Co-administration with strong CYP3A4 inhibitors may cause a clinically significant increase in Oxiten's systemic exposure (AUC/Cmax). Conversely, co-administration with strong CYP3A4 inducers may decrease Oxiten exposure, potentially affecting its efficacy.

The official profile includes specific notes for patients with hepatic or renal impairment, indicating that the relevance and severity of these interactions may be heightened in these specific populations.

Mechanism of Action

Molecular Mechanism: Non-Selective Enzyme Inhibition

Oxiten (Tenoxicam) primarily functions by reversibly inhibiting the activity of both the Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) enzymes. This interaction is the foundational step that directly prevents these enzymes from converting arachidonic acid into various downstream chemical mediators known as prostaglandins.

Physiological Cascade and Pathway Modulation

The inhibition of prostaglandin biosynthesis leads to a significant reduction in key inflammatory signals (PGE₂), responsible for sensitizing peripheral nociceptors and increasing local vascular permeability. Furthermore, this mechanism extends to the hypothalamic center to modulate the elevated temperature set-point, thereby contributing to a central thermal regulatory effect.

Mechanistic Constraints and Trade-offs ️

The non-selective action on COX-1, while integral to the mechanism, reduces the production of protective prostaglandins that support gastric mucosal protection and influence renal blood flow dynamics. This constraint illustrates a biological trade-off inherent to the mechanism, requiring the management of inflammatory signaling alongside effects on homeostatic pathways.

Dosage and Administration Information

How Oxiten is Used: Official Administration Guidelines

Oxiten (Tenoxicam) administration is standardized across its available forms and follows established administration guidelines.

Approved Administration Routes

Oxiten is administered via several routes, depending on the dosage form:

  • Oral: Tablets are the standard route for maintenance and acute continuation.
  • Systemic Injection (IV/IM): Lyophilized powder is used for initial, short-term treatment via intravenous (IV) or intramuscular (IM) bolus injection. The solution must not be used by infusion due to the risk of precipitation.
  • Other Routes: Suppositories (rectal) and Topical gel are also available forms, broadening the options for administration.

Standard Dosing Protocol

Standard regimens are based on a once-daily schedule, taken at the same time each day to maintain consistent levels.

Usage Context Official Dosing Regimen Duration/Adjustment Rule
Standard Daily Dose 20 mg once daily. May be reduced to 10 mg for long-term maintenance.
Acute Gout Initiation 40 mg once daily for the first two days. Followed by 20 mg once daily for five days.
IV/IM Initiation 20 mg once daily for one to two days. Immediately followed by oral or rectal administration.

Procedural and Population Rules

Intake Instructions: Oral tablets are swallowed whole, with or immediately after a meal, or with a glass of liquid. The powder for injection is dissolved in 2 mL of sterile water for injections and used immediately for bolus administration. If an oral dose is missed, the missed dose is skipped if close to the next scheduled time, and a double dose is not taken.

Population Adjustments: Older adults typically commence treatment using the lowest effective dose. For patients with renal impairment (creatinine clearance > 25 mL/min), the usual dosage is utilized with careful monitoring; no dosing recommendations exist for severe renal impairment. The use of Oxiten in the pediatric population is not recommended due to insufficient data.

Recent Clinical Evidence

Research evidence / Overview of Studies for Oxiten (Tenoxicam)


Research Evidence for Inflammatory Joint Conditions

The evidence for Oxiten in managing chronic joint conditions, specifically Osteoarthritis (OA) and Rheumatoid Arthritis (RA), is primarily derived from Randomized Controlled Trials and scientific reviews. These studies examined patient-reported outcomes related to physical discomfort and functional limitations. Findings describe patterns observed in the study populations, reporting changes measured over periods that often extend to six months.

However, comparative evidence is lacking against all treatments currently available, meaning the research mainly provides context regarding specific comparator treatments evaluated at the time of the trials. Also, limited information for long-term outcomes that fully establish the outcomes related to systemic or functional imbalance for periods much longer than one year are available.


Limited Research in Acute Pain Settings

Oxiten was evaluated in research settings exploring its use for acute or disruptive episodes of pain, such as that following surgical procedures. These studies typically examined outcomes related to supplemental pain medication use and the measurement of short-term pain intensity.

Major scientific reviews addressing the use of oral Oxiten for established acute postoperative pain have indicated that evidence is limited. These reviews report that evidence quality varies across studies, and high-quality, placebo-controlled trials often do not meet the strict criteria for research exploration in this specific context. Therefore, data are still emerging, and the available findings describe group patterns from limited data.


Research in Specific Patient Groups and Evidence Gaps

Studies of Oxiten were observed in patient populations that are frequently older adults, given the common diagnosis of joint conditions in this age group. Specifically, trials research examined how symptoms change over time in these older adult populations.

Significant evidence gaps remain for other specific groups. Data for certain groups remain insufficient, especially for pediatric populations and those with severe co-existing conditions. Additionally, follow-up durations were limited in many core studies, meaning that long-term effects are not fully established regarding sustained outcomes over many years of use. Finally, subgroup findings are uncertain when trying to draw conclusions for groups defined by rare or specific concurrent medical issues.

Key Studies & References

  1. Tenoxicam Devatis Powder for Injection, 20 mg - Medsafe Datasheet (Regulatory Document)

Frequently Asked Questions (FAQ)

Common questions about Oxiten (FAQ)

Q: What kind of foods or drinks should be avoided while taking Oxiten?

Official information describes that oral tablets are typically administered with or immediately following a meal, or with a glass of liquid. The drug's use is strongly restricted with alcohol because this combination carries a documented risk of severe, additive depressant effects. No other specific food restrictions are typically highlighted in the official guidelines.

Q: Is Oxiten safe to use for older adults (seniors)?

Official regulatory information indicates that treatment for older adults often commences with the lowest effective dose. This caution is necessary because older adults have an increased risk of adverse reactions to this class of drug, especially severe gastrointestinal events.

Q: Why do official documents mention Oxiten and liver function?

Official documents note that the drug may cause borderline elevations in liver tests. Therefore, special caution and monitoring are described in the label for patients with existing liver dysfunction. Severe liver reactions, including fatal hepatitis, have been reported rarely with this class of medication.

Q: What is the mechanism of action of Oxiten in simple terms?

According to regulatory sources, Oxiten works by interfering with the body's natural processes that create certain chemicals called prostaglandins. These prostaglandins are responsible for causing symptoms like inflammation, pain, and fever. By modulating this process, the drug helps relieve those symptoms.

Q: Who is considered ineligible to use Oxiten according to official warnings?

Official warnings describe specific conditions that contraindicate use, such as having an active peptic ulcer, a history of gastrointestinal bleeding related to this drug class, or known hypersensitivity to NSAIDs. The drug is also contraindicated in cases of severe heart, liver (hepatic), or kidney (renal) failure.

Q: Why is my doctor asking about my kidney health before starting Oxiten?

Official regulatory information warns that Oxiten belongs to a class of drugs that can affect kidney (renal) function, particularly in patients with existing impairment. It is contraindicated in severe renal failure, and the label indicates that caution is required because the drug can influence how the body handles sodium and water.

Q: What is the main reason doctors prescribe Oxiten?

Official regulatory documents indicate that Oxiten is used for the symptomatic treatment of painful inflammatory and degenerative musculoskeletal disorders. These officially approved uses include conditions such as rheumatoid arthritis, osteoarthritis, and acute gout.

Q: Does Oxiten cause weight gain or weight loss?

Official documents note that this drug, like others in its class, can sometimes be associated with fluid retention or edema (swelling). This effect is due to the drug influencing kidney function and may be reflected as a slight change in weight.

Q: Can Oxiten make you feel tired or sleepy?

Official documents list nervous system effects, such as dizziness and headache, as common side effects. Sleepiness, medically known as somnolence, is also noted as a possible, but less frequent, undesirable effect reported in official documents.

Q: What are the most commonly reported side effects of Oxiten?

According to official product information, the most commonly reported adverse effects involve the gastrointestinal system. These include nausea, abdominal pain, diarrhea, and indigestion (dyspepsia). Additionally, nervous system effects like headache and dizziness are also frequently noted.

Q: Is it normal to feel a mild headache when starting Oxiten?

Headache is listed among the commonly reported undesirable effects in the official regulatory documents for Oxiten.

Q: Can Oxiten affect your mood or emotional state?

Official documents list psychiatric disturbances as possible undesirable effects. These disturbances may include feelings of anxiety or changes in sleep patterns, according to official safety information.

Q: Does Oxiten interact with common over-the-counter pain relievers?

Official documents specifically describe that use of Oxiten together with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including common pain relievers like salicylates (such as aspirin), is cautioned against.

Q: Is Oxiten a controlled substance or addictive?

Oxiten is a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not classified as a controlled substance with abuse potential by major regulatory bodies.

Q: What are the concerns about taking Oxiten during pregnancy?

Official warnings state that Oxiten is contraindicated during the last trimester of pregnancy (after 20 weeks). This is due to the documented risk of fetal heart issues or potential kidney problems. The label indicates that use prior to 20 weeks requires careful assessment.

Q: Can women take Oxiten while breastfeeding?

Official regulatory documents state that the safety of Oxiten during lactation (breastfeeding) has not been established. Regulatory information describes that its use during breastfeeding is generally not recommended.

Q: Are there any restrictions on driving or operating machinery while on Oxiten?

Patients are officially cautioned that side effects such as dizziness, vertigo, or visual disturbances may occur while using the drug. The label indicates that caution is necessary when driving or operating machinery.

Q: What should I do if I think I'm having an allergic reaction to Oxiten?

Official regulatory documents clearly state that if you experience signs of a hypersensitivity reaction (such as asthma, itching, or rash) occur, withdrawal of the drug is indicated.

Q: Does Oxiten require any special monitoring or regular blood tests?

Official warnings describe that patients receiving long-term treatment with Oxiten may require special monitoring. This monitoring may include checks of kidney function, liver function, and blood count.

Q: Does Oxiten affect blood pressure?

Official documents indicate that caution is necessary in patients with uncontrolled high blood pressure (hypertension) or heart failure. The drug, like others in its class, may cause fluid retention and edema, which can affect blood pressure management.

Q: Is there a generic version of Oxiten available?

Oxiten is a brand name for the active ingredient Tenoxicam, which is the generic drug. The generic form of Tenoxicam is commonly available in many regions.

Q: Is Oxiten available over the counter?

Oxiten (Tenoxicam) is generally classified as a prescription-only medicine by major international drug regulatory bodies and is therefore not available over the counter.

Q: What is the chemical class or type of drug Oxiten belongs to?

Oxiten (Tenoxicam) is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). It belongs to a specific chemical group within that class known as the oxicam derivatives.

Q: How long does Oxiten stay in your system?

According to the official pharmacokinetics section, the time it takes for half of the drug to be eliminated from the body, known as the terminal half-life, is approximately 60 to 75 hours.

Q: Does Oxiten need to be refrigerated or stored in a special way?

The label specifies storage conditions at or below 30 C (about 86 F) and indicates the drug should be protected from both light and moisture to ensure stability.

Q: Does Oxiten have a 'Black Box Warning' in the official documents?

Yes, like all non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs), the drug carries an official Boxed Warning in regulatory documents. This warning relates to the risk of serious cardiovascular thrombotic events and serious gastrointestinal adverse events.

Q: Is Oxiten a new drug or has it been around for a long time?

The active ingredient in Oxiten, Tenoxicam, received its initial regulatory approval in many international markets in the mid-1980s. This indicates the drug has been available for a long time.

Q: Can Oxiten affect sleep patterns?

Official regulatory documents list psychiatric disturbances as possible undesirable effects. These disturbances include insomnia (difficulty sleeping) or somnolence (drowsiness), which can affect overall sleep patterns.

Q: Does the risk of side effects increase with long-term use of Oxiten?

Official warnings describe that minimizing undesirable effects may involve using the lowest effective dose for the shortest duration. Regulatory documents specifically note that the risk of serious gastrointestinal events, such as bleeding and ulceration, increases with the duration of use.

Q: Can Oxiten cause sensitivity to sunlight?

Official documents list various skin reactions as undesirable effects. Rarely, this may include photosensitivity, which means an increased sensitivity or reaction to exposure to sunlight.

Q: Why do some people say Oxiten caused stomach upset?

According to official documents, gastrointestinal issues are among the most commonly reported side effects. These include dyspepsia (indigestion), nausea, abdominal pain, and diarrhea.

Q: Is it true that Oxiten can cause dizziness?

Yes, dizziness is listed among the commonly reported undesirable effects in the official regulatory documents for Oxiten.

Q: Are there any known severe side effects of Oxiten?

Yes, official warnings cover the potential for serious adverse events. These include serious cardiovascular events, severe gastrointestinal bleeding or ulceration, and rare but severe cutaneous reactions (serious skin conditions).

How should Oxiten be stored and disposed of?

How to Store and Dispose of Oxiten (Tenoxicam)

Official regulatory documents define strict conditions for storing and discarding Oxiten to maintain its quality and prevent misuse.


Storage Conditions

Oxiten must be stored at room temperature, typically below 30°C, and must be protected from light and moisture. The medicine must be kept in its original container or blister package, which should be tightly closed.

Handling Constraint Requirement
Child Safety Keep out of the sight and reach of children and pets.
Injection Stability Reconstituted solution must be used immediately or stored at 2°C to 8°C for a maximum of 24 hours.

Disposal Instructions

Unused or expired Oxiten must not be thrown into wastewater or household waste. Disposal should be done in accordance with local requirements.

Patients should consult a pharmacist about local take-back programs to ensure the product is discarded safely.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxiten found in:

A-Z Index: